Clinical trial

A Study of Staccato Loxapine (ADASUVE®) for Inhalation

NCT04148963

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-12-01

PhasePHASE3

Study timeline

Study start (estimated)2019-12-01Date precision: day

Registry last updated2019-11-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychomotor Agitationunresolved

Schizophreniaunresolved

Bipolar Disorderunresolved

Interventions

Inhaled loxapineDRUG

Inhaled placeboDRUG

Sponsors & collaborators

Lee's Pharmaceutical Limitedlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04148963 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.